Standard Chemical & Pharmaceutical Co (TPE:1720) Other Current Payables: NT$591 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:1720 Standard Chemical & Pharmaceutical Co Ltd TPE:1720
95 GF Score
Price NT$56.10
GF Value NT$64.61
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Standard Chemical & Pharmaceutical Co Other Current Payables?

Standard Chemical & Pharmaceutical Co TPE:1720 -2.82% 95 Other Current Payables is NT$591 Mil as of Dec. 2025. GuruFocus rates TPE:1720 with a GF Score™ of 95/100 and a GF Value™ of NT$64.61 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Standard Chemical & Pharmaceutical Co's Other Current Payables for the quarter that ended in Dec. 2025 was NT$591 Mil.

Standard Chemical & Pharmaceutical Co's quarterly Other Current Payables declined from Jun. 2025 (NT$1,237 Mil) to Sep. 2025 (NT$547 Mil) but then increased from Sep. 2025 (NT$547 Mil) to Dec. 2025 (NT$591 Mil).

Standard Chemical & Pharmaceutical Co's annual Other Current Payables increased from Dec. 2023 (NT$526 Mil) to Dec. 2024 (NT$573 Mil) and increased from Dec. 2024 (NT$573 Mil) to Dec. 2025 (NT$591 Mil).

Standard Chemical & Pharmaceutical Co Other Current Payables Related Terms

Standard Chemical & Pharmaceutical Co Other Current Payables Historical Data

* Premium members only.

The historical data trend for Standard Chemical & Pharmaceutical Co's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Standard Chemical & Pharmaceutical Co Other Current Payables Chart

Standard Chemical & Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Payables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 454.44 515.55 525.59 573.38 591.30

Standard Chemical & Pharmaceutical Co Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 573.38 1,173.58 1,236.52 547.02 591.30
TPE:1720
95GF Score
Standard Chemical & Pharmaceutical Co Ltd TPE:1720
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Standard Chemical & Pharmaceutical Co Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of NT$591 Mil mean?
Standard Chemical & Pharmaceutical Co (TPE:1720) has a Other Current Payables of NT$591 Mil as of Dec. 2025. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Standard Chemical & Pharmaceutical Co and its competitors.
Is Standard Chemical & Pharmaceutical Co's Other Current Payables too high?
Standard Chemical & Pharmaceutical Co's current Other Current Payables is NT$591 Mil. Overall, Standard Chemical & Pharmaceutical Co has a GF Score™ of 95/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Standard Chemical & Pharmaceutical Co's Other Current Payables compare to ZTS and UTHR?
Standard Chemical & Pharmaceutical Co's Other Current Payables of NT$591 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Drug Manufacturers company?
A good Other Current Payables depends on the Drug Manufacturers industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Standard Chemical & Pharmaceutical Co and its competitors. Standard Chemical & Pharmaceutical Co's current Other Current Payables is NT$591 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Standard Chemical & Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Standard Chemical & Pharmaceutical Co (TPE:1720) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$64.61, compared to a current price of NT$56.10 — trading 13.2% below its estimated fair value. The current Other Current Payables is NT$591 Mil. Standard Chemical & Pharmaceutical Co's overall GF Score™ is 95/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For Standard Chemical & Pharmaceutical Co (TPE:1720), the current Other Current Payables is NT$591 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Standard Chemical & Pharmaceutical Co (TPE:1720) Overvalued in 2026?

Based on GuruFocus' analysis, Standard Chemical & Pharmaceutical Co stock appears to be undervalued. The current stock price of NT$56.10 is trading 13.2% below its estimated GF Value™ of NT$64.61. GuruFocus considers Standard Chemical & Pharmaceutical Co to be Modestly Undervalued.

Key valuation signals for TPE:1720:

  • Other Current Payables: NT$591 Mil
  • GF Value™: NT$64.61 vs. price of NT$56.10 (13.2% below fair value)
  • GF Score™: 95/100 with 2 warning signs

No single metric tells the full story. See the TPE:1720 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Standard Chemical & Pharmaceutical Co Business Description

Address No.6-20,Tuku, Sinying District, Tuku Village, Tainan, TWN, 73055
Standard Chemical & Pharmaceutical Co Ltd is engaged in the manufacturing and sales of Chinese and western medicine, cosmetics, beverage, normal instruments and medical instruments. Its segments include Medicine, Dietary supplement and Ingredients. The majority of the revenue is derived from the Medicine segment. Geographically it operates in Taiwan, Japan and Others with Taiwan generating the maximum revenue.
95GF Score

Get the complete analysis for TPE:1720

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$56.10
Price
NT$64.61
GF Value